Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2019 4
2020 3
2021 3
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant systemic therapy in high-risk melanoma.
Blankenstein SA, van Akkooi ACJ. Blankenstein SA, et al. Melanoma Res. 2019 Aug;29(4):358-364. doi: 10.1097/CMR.0000000000000604. Melanoma Res. 2019. PMID: 30896556 Review.
Surgery for Metastatic Melanoma: an Evolving Concept.
Testori AAE, Blankenstein SA, van Akkooi ACJ. Testori AAE, et al. Among authors: blankenstein sa. Curr Oncol Rep. 2019 Nov 6;21(11):98. doi: 10.1007/s11912-019-0847-6. Curr Oncol Rep. 2019. PMID: 31696407 Review.
Primary Melanoma: from History to Actual Debates.
Testori AAE, Blankenstein SA, van Akkooi ACJ. Testori AAE, et al. Among authors: blankenstein sa. Curr Oncol Rep. 2019 Dec 19;21(12):112. doi: 10.1007/s11912-019-0843-x. Curr Oncol Rep. 2019. PMID: 31858280 Review.
Postoperative radiotherapy in stage I-III Merkel cell carcinoma.
Levy S, Blankenstein SA, Grünhagen DJ, Jalving M, Hamming-Vrieze O, Been LB, Tans L, van Akkooi ACJ, Tesselaar MET. Levy S, et al. Among authors: blankenstein sa. Radiother Oncol. 2022 Jan;166:203-211. doi: 10.1016/j.radonc.2021.11.017. Epub 2021 Nov 25. Radiother Oncol. 2022. PMID: 34838887 Free article.
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
Boshuizen J, Vredevoogd DW, Krijgsman O, Ligtenberg MA, Blankenstein S, de Bruijn B, Frederick DT, Kenski JCN, Parren M, Brüggemann M, Madu MF, Rozeman EA, Song JY, Horlings HM, Blank CU, van Akkooi ACJ, Flaherty KT, Boland GM, Peeper DS. Boshuizen J, et al. Among authors: blankenstein s. Nat Commun. 2020 Aug 7;11(1):3946. doi: 10.1038/s41467-020-17739-8. Nat Commun. 2020. PMID: 32770055 Free PMC article.
Broadening indications for neoadjuvant immunotherapy.
Blankenstein SA, van Akkooi ACJ. Blankenstein SA, et al. Br J Dermatol. 2020 Sep;183(3):421-422. doi: 10.1111/bjd.18873. Epub 2020 Feb 3. Br J Dermatol. 2020. PMID: 32017031 No abstract available.
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
Boshuizen J, Vredevoogd DW, Krijgsman O, Ligtenberg MA, Blankenstein S, de Bruijn B, Frederick DT, Kenski JCN, Parren M, Brüggemann M, Madu MF, Rozeman EA, Song JY, Horlings HM, Blank CU, van Akkooi ACJ, Flaherty KT, Boland GM, Peeper DS. Boshuizen J, et al. Among authors: blankenstein s. Nat Commun. 2023 Feb 7;14(1):672. doi: 10.1038/s41467-023-35852-2. Nat Commun. 2023. PMID: 36750559 Free PMC article. No abstract available.
Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
Versluis JM, Blankenstein SA, Dimitriadis P, Wilmott JS, Elens R, Blokx WAM, van Houdt W, Menzies AM, Schrage YM, Wouters MWJM, Sanders J, Broeks A, Scolyer RA, Suijkerbuijk KPM, Long GV, Akkooi ACJV, Blank CU. Versluis JM, et al. Among authors: blankenstein sa. J Immunother Cancer. 2024 Apr 27;12(4):e008125. doi: 10.1136/jitc-2023-008125. J Immunother Cancer. 2024. PMID: 38677880 Free PMC article.
18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients: Can (Early) Metabolic Imaging Predict Histopathologic Response or Recurrence?
van der Hiel B, Blankenstein SA, Aalbersberg EA, Wondergem M, Stokkel MPM, van de Wiel BA, Klop WMC, van Akkooi ACJ, Haanen JB. van der Hiel B, et al. Among authors: blankenstein sa. Clin Nucl Med. 2022 Jul 1;47(7):583-589. doi: 10.1097/RLU.0000000000004217. Epub 2022 Apr 22. Clin Nucl Med. 2022. PMID: 35452004
15 results